Schoenberg Mark's Form 4 filing
UroGen Pharma Ltd. (URGN) · filed Feb 2, 2024
- Accession no.
- 0001437749-24-003016
- Filed
- Feb 2, 2024
- Trade date
- Jan 31, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $59.6K. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001437749-24-003153 (Feb 5, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schoenberg MarkCIK 0001763581 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 | Ordinary Shares | MOption exerciseAcquired | +2,000 | – | – | 150,560 | Direct | |
| Jan 31, 2024 | Ordinary Shares | SSaleDisposed | −1,137 | $15.74 | −$17,896.38 | 149,423 | Direct | |
| Jan 31, 2024 | Ordinary Shares | MOption exerciseAcquired | +1,333 | – | – | 150,756 | Direct | |
| Jan 31, 2024 | Ordinary Shares | SSaleDisposed | −758 | $15.74 | −$11,930.92 | 149,998 | Direct | |
| Jan 31, 2024 | Ordinary Shares | MOption exerciseAcquired | +3,333 | – | – | 153,331 | Direct | |
| Jan 31, 2024 | Ordinary Shares | SSaleDisposed | −1,894 | $15.74 | −$29,811.56 | 151,437 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 | Ordinary Shares | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 0 | Direct | |
| Jan 31, 2024 | Ordinary Shares | MOption exerciseDisposed | −1,333 | $0.00 | $0 | 1,334 | Direct | |
| Jan 31, 2024 | Ordinary Shares | MOption exerciseDisposed | −3,333 | $0.00 | $0 | 6,667 | Direct | |
| Jan 31, 2024 | Ordinary Shares | AGrant or awardAcquired | +10,000 | $0.00 | $0 | 10,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.